399 related articles for article (PubMed ID: 16048833)
1. Criminal involvement among young male ecstasy users.
Hendrickson JC; Gerstein DR
Subst Use Misuse; 2005; 40(9-10):1557-75. PubMed ID: 16048833
[TBL] [Abstract][Full Text] [Related]
2. Club drug use in Germany.
Soellner R
Subst Use Misuse; 2005; 40(9-10):1279-93. PubMed ID: 16048817
[TBL] [Abstract][Full Text] [Related]
3. The varieties of ecstatic experience: an exploration of the subjective experiences of ecstasy.
Sumnall HR; Cole JC; Jerome L
J Psychopharmacol; 2006 Sep; 20(5):670-82. PubMed ID: 16401654
[TBL] [Abstract][Full Text] [Related]
4. The epidemiology of ecstasy use and harms in Australia.
Degenhardt L; Roxburgh A; Dunn M; Campbell G; Bruno R; Kinner SA; George J; Quinn B; White N; Topp L
Neuropsychobiology; 2009; 60(3-4):176-87. PubMed ID: 19893334
[TBL] [Abstract][Full Text] [Related]
5. Memory performance in polyvalent MDMA (ecstasy) users who continue or discontinue MDMA use.
Gouzoulis-Mayfrank E; Fischermann T; Rezk M; Thimm B; Hensen G; Daumann J
Drug Alcohol Depend; 2005 Jun; 78(3):317-23. PubMed ID: 15893163
[TBL] [Abstract][Full Text] [Related]
6. Modelling the adverse effects associated with ecstasy use.
Fisk JE; Murphy PN; Montgomery C; Hadjiefthyvoulou F
Addiction; 2011 Apr; 106(4):798-805. PubMed ID: 21182557
[TBL] [Abstract][Full Text] [Related]
7. Ecstasy (MDMA) and memory function: a meta-analytic update.
Laws KR; Kokkalis J
Hum Psychopharmacol; 2007 Aug; 22(6):381-8. PubMed ID: 17621368
[TBL] [Abstract][Full Text] [Related]
8. Neural mechanisms of working memory in ecstasy (MDMA) users who continue or discontinue ecstasy and amphetamine use: evidence from an 18-month longitudinal functional magnetic resonance imaging study.
Daumann J; Fischermann T; Heekeren K; Thron A; Gouzoulis-Mayfrank E
Biol Psychiatry; 2004 Sep; 56(5):349-55. PubMed ID: 15336517
[TBL] [Abstract][Full Text] [Related]
9. Is emotional intelligence impaired in ecstasy-polydrug users?
Craig L; Fisk JE; Montgomery C; Murphy PN; Wareing M
J Psychopharmacol; 2010 Feb; 24(2):221-31. PubMed ID: 18801831
[TBL] [Abstract][Full Text] [Related]
10. Cognitive performance in recreational ecstasy polydrug users: a two-year follow-up study.
de Sola Llopis S; Miguelez-Pan M; Peña-Casanova J; Poudevida S; Farré M; Pacifici R; Böhm P; Abanades S; Verdejo García A; Langohr K; Zuccaro P; de la Torre R
J Psychopharmacol; 2008 Jul; 22(5):498-510. PubMed ID: 18208910
[TBL] [Abstract][Full Text] [Related]
11. Adverse symptomatology and suicide associated with the use of methylenedioxymethamphetamine (MDMA; "Ecstasy").
Cohen RS
Biol Psychiatry; 1996 May; 39(9):819-20. PubMed ID: 8731525
[No Abstract] [Full Text] [Related]
12. Unhealthy weight control behaviors and MDMA (Ecstasy) use among adolescent females.
Cance JD; Ashley OS; Penne MA
J Adolesc Health; 2005 Nov; 37(5):409. PubMed ID: 16227128
[TBL] [Abstract][Full Text] [Related]
13. Increased intensity of Ecstasy and polydrug usage in the more experienced recreational Ecstasy/MDMA users: a WWW study.
Scholey AB; Parrott AC; Buchanan T; Heffernan TM; Ling J; Rodgers J
Addict Behav; 2004 Jun; 29(4):743-52. PubMed ID: 15135556
[TBL] [Abstract][Full Text] [Related]
14. Pathways into ecstasy use: the role of prior cannabis use and ecstasy availability.
Zimmermann P; Wittchen HU; Waszak F; Nocon A; Höfler M; Lieb R
Drug Alcohol Depend; 2005 Sep; 79(3):331-41. PubMed ID: 15913921
[TBL] [Abstract][Full Text] [Related]
15. Crystal methamphetamine smoking among regular ecstasy users in Australia: increases in use and associations with harm.
Kinner SA; Degenhardt L
Drug Alcohol Rev; 2008 May; 27(3):292-300. PubMed ID: 18368611
[TBL] [Abstract][Full Text] [Related]
16. Neurotoxicity of methylenedioxyamphetamines (MDMA; ecstasy) in humans: how strong is the evidence for persistent brain damage?
Gouzoulis-Mayfrank E; Daumann J
Addiction; 2006 Mar; 101(3):348-61. PubMed ID: 16499508
[TBL] [Abstract][Full Text] [Related]
17. Ecstasy use in New Zealand: findings from the 1998 and 2001 National Drug Surveys.
Wilkins C; Bhatta K; Pledger M; Casswell S
N Z Med J; 2003 Apr; 116(1171):U383. PubMed ID: 12740633
[TBL] [Abstract][Full Text] [Related]
18. Ecstasy (MDMA) exposure and neuropsychological functioning: a polydrug perspective.
Medina KL; Shear PK; Corcoran K
J Int Neuropsychol Soc; 2005 Oct; 11(6):753-65. PubMed ID: 16248911
[TBL] [Abstract][Full Text] [Related]
19. MDMA and sexual behavior: ecstasy users' perceptions about sexuality and sexual risk.
McElrath K
Subst Use Misuse; 2005; 40(9-10):1461-77. PubMed ID: 16048828
[TBL] [Abstract][Full Text] [Related]
20. Evidence for executive deficits among users of MDMA (Ecstasy).
Fisk JE; Montgomery C; Murphy P; Wareing M
Br J Psychol; 2004 Nov; 95(Pt 4):457-66. PubMed ID: 15527532
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
